Risk Factors and Biomarkers for Post-tuberculosis Lung Damage
ConditionPulmonary TB
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age25-60
SponsorPeking University Third Hospital
About this trial
This prospective study aims to determine the incidence of Post-tuberculosis lung damage (PTLD), examine trends in the changes in lung function, and investigate the impact of smoking and other factors on respiratory symptoms, lung function, and chest CT findings, which will aid in the development of prognostic and therapeutic strategies for PTLD.
Eligibility criteria
Qualifiers
None
Disqualifiers
patients with positive sputum smear or TB culture results;
human immunodeficiency virus-positive patients;
patients infected with multidrug-resistant TB;
patients with malignant neoplasms (e.g., lung cancer) or severe cardiovascular and cerebrovascular diseases;
Trial design
Treatments tested in this trial
- no intervention
Treatment groups
400 Participants
are divided into 1 treatment groupSponsors and collaborators
Peking University Third Hospital
Lead sponsor
Beijing Geriatric Hospital
Collaborator
Source ClinicalTrials.gov